Alkem Laboratories Limited (ALKEM.NS) NSE
5,274.00
+35(+0.67%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
5,274.00
+35(+0.67%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
17432
First IPO Date
December 23, 2015
| Name | Title | Pay | Year Born |
| Vikas Gupta | Chief Executive Officer | 0 | N/A |
| Nitin Agrawal | Chief Financial Officer & President of Finance | 21.5M | N/A |
| Sandeep Derjit Singh | MD & Executive Director | 97.5M | 1982 |
| Mritunjay Kumar Singh | Executive Director | 123.6M | 1963 |
| Srinivas Singh | Executive Director | 123.6M | 1988 |
| Madhurima Singh | Executive Director | 123.6M | 1965 |
| Basudeo Narian Singh | Executive Chairman | 214.3M | 1941 |
| Akhilesh D. Sharma | President & Chief Medical Officer | 0 | 1969 |
| Rajorshi Ganguli | President & Global HR Head | 0 | 1971 |
| Shirish Purushotham Ambulgekar | President & Global Quality Head | 0 | N/A |
Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, oncology, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. It also provides pregnancy detection kits and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.